Event Details
Ocular Therapeutix, Inc.Announces Topline Results of Second Phase 3 Clinical Trial of DEXTENZA™ for the Treatment of Allergic Conjunctivitis
June 6, 2016 at 8:30 AM EDT
Live Teleconference Information
Primary # -
Secondary # -
Replay Teleconference Information
Start Date -
Jun 6, 2016 at 10:30 AM EDT
Primary # -
Secondary # -
Passcode -
27710660
